autism
21
That’s the number federal autism advisers that health secretary Robert F. Kennedy Jr. appointed yesterday.
Many of the new members of the Interagency Autism Coordinating Committee have questioned the established science that vaccines do not cause autism, according to O. Rose Broderick.
Some of the new members have already recently met in private, and Rose reported that the autism community is concerned that many of the new appointees are members of the Make America Healthy Again movement.
Read more.
drug prices
Here comes TrumpRx
The administration has said it would launch TrumpRx sometime in January. And as the month nears an end, the White House is expected to launch the website on Friday, according to drug lobbyists and this MS NOW reporter.
It’s not clear how it will work, but medicines will not be for sale on TrumpRx, according to the placeholder site. Instead, it’s expected to point consumers to where they can find the lowest prices by buying directly from drugmakers.
Chelsea Cirruzzo called the White House about the launch but didn’t get a response.
medicare price negotiation
Shelter for expensive drugs
The Trump administration on Tuesday released the next 15 drugs subject to Medicare price negotiation, including for the first time treatments administered in doctor offices.
The list includes some HIV and cancer drugs that could save the government a lot of money due to their protected status in Medicare.
But I neglected to mention in the story that a few other drugs with the potential for major savings were likely excluded from the list, thanks to Republicans’ tax bill. That bill delayed or exempted from negotiation drugs that treat multiple rare diseases, including Keytruda, and delayed Medicare negotiation for drugs first approved as orphans and later approved for wider use. The nonpartisan Congressional Budget Office estimated that measure to cost $8.8 billion over a decade.
Read more.
insurance
Tough luck
Health insurers had hoped that the Trump administration would alleviate the problems that they’ve endured in Medicare Advantage over the past three years.
But in the words of Bob Herman, “Tough luck, for now.”
The administration proposed a minuscule pay hike for Medicare Advantage that surprised investors and sent stocks tumbling for the largest sellers of private Medicare plans, including UnitedHealth Group, Humana, CVS Health, and Elevance Health.
Read more about the challenges that industry faces in getting the administration to increase payment rates.